PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Yang G et al. Systemic PPARγ deletion impairs circadian rhythms of behavior and metabolism. 2012 PLoS ONE pmid:22899986
Nicholson JD et al. PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema. 2012 PLoS ONE pmid:23284631
Wang Y et al. Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism. 2012 Bioorg. Med. Chem. Lett. pmid:22119474
Alba G et al. Transcription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophils. 2012 PLoS ONE pmid:23115616
Hossain MS et al. Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids. 2012 Exp. Cell Res. pmid:22100987
Pettipher R et al. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. 2012 J. Pharmacol. Exp. Ther. pmid:22106101
Paulitschke V et al. Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction. 2012 PLoS ONE pmid:23049949
Bain G et al. Pharmacodynamics, pharmacokinetics, and safety of AM211: a novel and potent antagonist of the prostaglandin D2 receptor type 2. 2012 J Clin Pharmacol pmid:22110163
Syeda PK et al. A monoclonal antibody specific for Δ12-prostaglandin J2 and its utilization in the immunological assay in cell culture system of adipocytes. 2012 Hybridoma (Larchmt) pmid:23098304
Gates D et al. Apo J/clusterin expression and secretion: evidence for 15-deoxy-Δ(12,14)-PGJ(2)-dependent mechanism. 2012 Biochim. Biophys. Acta pmid:22138303
Weng Y et al. Prostaglandin metabolite induces inhibition of TRPA1 and channel-dependent nociception. 2012 Mol Pain pmid:23013719
Ravindra KC et al. Targeting of histone acetyltransferase p300 by cyclopentenone prostaglandin Δ(12)-PGJ(2) through covalent binding to Cys(1438). 2012 Chem. Res. Toxicol. pmid:22141352
Maurer M and Church MK Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistamines. 2012 Exp. Dermatol. pmid:22142018
Fujimori K et al. Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase. 2012 J. Neurochem. pmid:22043816
Sedej M et al. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells. 2012 J. Allergy Clin. Immunol. pmid:21930295
Higuchi S et al. Involvement of Th2 cytokines in the mouse model of flutamide-induced acute liver injury. 2012 J Appl Toxicol pmid:21735453
Pasvanis S et al. High sodium butyrate levels induce MDR1 activation in colorectal cells: Impact of 15-deoxy-Δ(12,14)-prostaglandin J(2) on the resistance to saquinavir. 2012 Biochem. Biophys. Res. Commun. pmid:22293191
Li X et al. Natural vanadium-containing Jeju groundwater inhibits immunoglobulin E-mediated anaphylactic reaction and suppresses eicosanoid generation and degranulation in bone marrow derived-mast cells. 2012 Biol. Pharm. Bull. pmid:22293352
He S et al. Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella). 2012 Comp. Biochem. Physiol. C Toxicol. Pharmacol. pmid:22079418
Clemente-Napimoga JT et al. 15d-PGJ2-loaded in nanocapsules enhance the antinociceptive properties into rat temporomandibular hypernociception. 2012 Life Sci. pmid:22564409
Inceoglu AB et al. Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice. 2012 J. Cardiovasc. Pharmacol. pmid:22526297
Higashi N et al. Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. 2012 Allergol Int pmid:22627848
Kristensen DM et al. Paracetamol (acetaminophen), aspirin (acetylsalicylic acid) and indomethacin are anti-androgenic in the rat foetal testis. 2012 Int. J. Androl. pmid:22612476
Hogrefe C et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. 2012 Int. J. Mol. Med. pmid:22922824
Lee E et al. 15-Deoxy-Δ12,14-prostaglandin J₂ modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes. 2012 Free Radic. Biol. Med. pmid:22245093
Lee S et al. Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects. 2012 J. Biol. Chem. pmid:22275363
Ledwidge MT et al. In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin? 2012 Atherosclerosis pmid:22326030
Baek K et al. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow. 2012 J. Cell. Physiol. pmid:22307523
Mantel A et al. Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis. 2012 J. Invest. Dermatol. pmid:22170488
Farnesi-de-Assunção TS et al. PPAR-γ agonists, mainly 15d-PGJ(2), reduce eosinophil recruitment following allergen challenge. 2012 Cell. Immunol. pmid:22192475
Kuriyan AE et al. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring. 2012 Exp. Eye Res. pmid:22178289
Yang K et al. [Changes of prostaglandin D2,carboxypeptidase A3 and platelet activating factor in guinea pig in anaphylactic shock]. 2012 Fa Yi Xue Za Zhi pmid:22812216
Komoda T and Nishikawa M 6'-Hydroxyoxosorbicillinol, a new lipoxygenase inhibitor and PGD2/LTB4 release suppressor from Penicillium sp. 2012 Biosci. Biotechnol. Biochem. pmid:22785490
Joo M and Sadikot RT PGD synthase and PGD2 in immune resposne. 2012 Mediators Inflamm. pmid:22791937
Baudouin-Legros M et al. Long-term CFTR inhibition modulates 15d-prostaglandin J2 in human pulmonary cells. 2012 Int. J. Biochem. Cell Biol. pmid:22481026
Weng Z et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. 2012 PLoS ONE pmid:22470478
Takahashi G et al. The potential role of prostaglandin D2 in nasal congestion observed in a guinea pig model of allergic rhinitis. 2012 Int. Arch. Allergy Immunol. pmid:22472859
Abdo H et al. The omega-6 fatty acid derivative 15-deoxy-Δ¹²,¹⁴-prostaglandin J2 is involved in neuroprotection by enteric glial cells against oxidative stress. 2012 J. Physiol. (Lond.) pmid:22473776
Ji Y et al. Activation of rat intestinal mucosal mast cells by fat absorption. 2012 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:22461027
Liu X et al. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines. 2012 Eur. J. Cell Biol. pmid:22560326
Gross-Sondej I et al. [Measurement of bronchoconstrictive eicosanoids in chronic obstructive pulmonary disease]. 2012 Pneumonol Alergol Pol pmid:22370980
Han Z et al. 15-deoxy-Δ12,14 -prostaglandin J2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice. 2012 Hepatology pmid:22371273
Syeda PK et al. Generation of monoclonal antibody for 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ and development of enzyme-linked immunosorbent assay for its quantification in culture medium of adipocytes. 2012 Appl. Biochem. Biotechnol. pmid:22391692
Quinteiro MS et al. The indirect antinociceptive mechanism of 15d-PGJ2 on rheumatoid arthritis-induced TMJ inflammatory pain in rats. 2012 Eur J Pain pmid:22354681
Prage EB et al. Observation of two modes of inhibition of human microsomal prostaglandin E synthase 1 by the cyclopentenone 15-deoxy-Δ(12,14)-prostaglandin J(2). 2012 Biochemistry pmid:22356188
Numazawa S et al. Possible involvement of transient receptor potential channels in electrophile-induced insulin secretion from RINm5F cells. 2012 Biol. Pharm. Bull. pmid:22382320
Lin YC et al. The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells. 2012 Free Radic. Biol. Med. pmid:22387200
Carsin A et al. [Physiopathology of aspirin intolerant asthma]. 2012 Rev Mal Respir pmid:22405107
Song WL et al. Niacin and biosynthesis of PGDâ‚‚by platelet COX-1 in mice and humans. 2012 J. Clin. Invest. pmid:22406532
Nagata N and Urade Y [Endogenous sleep-promoting substance]. 2012 Nippon Rinsho pmid:22844810
Philipose S et al. Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation. 2012 PLoS ONE pmid:22870195
Wingard CJ et al. Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. 2011 Nanotoxicology pmid:21043986
Joachim A and Ruttkowski B Prostaglandin D(2) synthesis in Oesophagostomum dentatum is mediated by cytosolic glutathione S-transferase. 2011 Exp. Parasitol. pmid:21056037
Lotz C et al. Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning. 2011 Exp. Physiol. pmid:21123361
Tsujita T et al. Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish. 2011 Genes Cells pmid:21143560
Neri T et al. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. 2011 Eur. Respir. J. pmid:21148223
Kumar VB et al. Angiogenic effect of laminin involves modulation of cyclooxygenase-2 and prostaglandin levels. 2011 Exp. Biol. Med. (Maywood) pmid:21148739
Higuchi S et al. IL-4 mediates dicloxacillin-induced liver injury in mice. 2011 Toxicol. Lett. pmid:21094227
Afrin LB Polycythemia from mast cell activation syndrome: lessons learned. 2011 Am. J. Med. Sci. pmid:21642812
Kajiwara D et al. Role of hematopoietic prostaglandin D synthase in biphasic nasal obstruction in guinea pig model of experimental allergic rhinitis. 2011 Eur. J. Pharmacol. pmid:21645503
Erttmann SF et al. PGD2 and PGE2 regulate gene expression of Prx 6 in primary macrophages via Nrf2. 2011 Free Radic. Biol. Med. pmid:21651978
Chiba T et al. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration. 2011 Ann. Allergy Asthma Immunol. pmid:21624751
Liu TY et al. [Advances in the study of histaminergic systems and sleep-wake regulation]. 2011 Yao Xue Xue Bao pmid:21626776
Zhang Y et al. Simultaneous and high-throughput quantitation of urinary tetranor PGDM and tetranor PGEM by online SPE-LC-MS/MS as inflammatory biomarkers. 2011 J Mass Spectrom pmid:21706677
Ugajin T et al. FcεRI, but not FcγR, signals induce prostaglandin D2 and E2 production from basophils. 2011 Am. J. Pathol. pmid:21712025
Tobiasova Z et al. Peroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells. 2011 Circulation pmid:21690493
Ebersberger A et al. Effects of prostaglandin D2 on tetrodotoxin-resistant Na+ currents in DRG neurons of adult rat. 2011 Pain pmid:21345590
Huang ZL et al. The role of adenosine in the regulation of sleep. 2011 Curr Top Med Chem pmid:21401496
Osanai T and Okumura K Lipocalin-type PGD synthase as a novel biomarker for coronary vasospasm. 2011 Circ. J. pmid:21378446
Du H et al. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. 2011 Br. J. Pharmacol. pmid:21501147
Varma D et al. Comparison of UHPLC and HPLC methods for the assay of prostanoids: "are the methods equivalent in terms of accuracy and precision?". 2011 Bioanalysis pmid:21510759
Kamauchi S and Urade Y [Hematopoietic prostaglandin D synthase inhibitors for the treatment of duchenne muscular dystrophy]. 2011 Brain Nerve pmid:22068479
Raman P et al. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. 2011 Mol. Pharmacol. pmid:21511917
Leamy AW et al. Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. 2011 Neurosci. Lett. pmid:21855605
Lin TH et al. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. 2011 J. Cell. Physiol. pmid:21344384
Zheng S et al. Novel biphasic role of LipoxinA(4) on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts. 2011 Mediators Inflamm. pmid:21765620
Lalier L et al. Prostaglandins antagonistically control Bax activation during apoptosis. 2011 Cell Death Differ. pmid:20966963
Hernandez JM and Janssen LJ Thromboxane prostanoid receptor activation amplifies airway stretch-activated contractions assessed in perfused intact bovine bronchial segments. 2011 J. Pharmacol. Exp. Ther. pmid:21768224
Sharma I et al. In vitro effects of peroxisome proliferator-activated receptor-γ ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells. 2011 Fertil. Steril. pmid:20970133
Tanaka A et al. Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2. 2011 Am. J. Physiol., Cell Physiol. pmid:21865589
Larsson AK et al. Prostaglandin Dâ‚‚ induces contractions through activation of TP receptors in peripheral lung tissue from the guinea pig. 2011 Eur. J. Pharmacol. pmid:21872585
Degousee N et al. Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia. 2011 J. Biol. Chem. pmid:21849511
Mesquita-Santos FP et al. Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils. 2011 Br. J. Pharmacol. pmid:20973774
Wienecke T et al. Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin Dâ‚‚ (PGDâ‚‚). 2011 Cephalalgia pmid:20974593
El-Shazly AE et al. IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. 2011 Int. Immunopharmacol. pmid:21835268
Kuehn HS et al. Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release. 2011 J. Biol. Chem. pmid:20980255
Surh YJ et al. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. 2011 Biochem. Pharmacol. pmid:21843512
Lu Y et al. Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. 2011 Biochem. Pharmacol. pmid:21907188
Burke SJ and Collier JJ The gene encoding cyclooxygenase-2 is regulated by IL-1β and prostaglandins in 832/13 rat insulinoma cells. 2011 Cell. Immunol. pmid:21885043
Crosignani S et al. Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases. 2011 J. Med. Chem. pmid:21916510
Nabe T et al. Inhibition of hematopoietic prostaglandin D synthase improves allergic nasal blockage in guinea pigs. 2011 Prostaglandins Other Lipid Mediat. pmid:21601002
Joos H et al. Single impact trauma in human early-stage osteoarthritic cartilage: implication of prostaglandin D2 but no additive effect of IL-1β on cell survival. 2011 Int. J. Mol. Med. pmid:21567074
Shao Z et al. Choroidal involution is a key component of oxygen-induced retinopathy. 2011 Invest. Ophthalmol. Vis. Sci. pmid:21546530
Ji Y et al. Nutrient-induced inflammation in the intestine. 2011 Curr Opin Clin Nutr Metab Care pmid:21587069
Jakob S and Lovell-Badge R Sex determination and the control of Sox9 expression in mammals. 2011 FEBS J. pmid:21281448
Hardy KD et al. Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo. 2011 J. Lipid Res. pmid:20944061
Wang P et al. Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1. 2011 FASEB J. pmid:21715681
Ahmed SR et al. Prostaglandin D2 regulates CD4+ memory T cell trafficking across blood vascular endothelium and primes these cells for clearance across lymphatic endothelium. 2011 J. Immunol. pmid:21715691
Yu R et al. Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2. 2011 J. Pharmacol. Exp. Ther. pmid:21865441
Koyama J et al. Simultaneous determination of histamine and prostaglandin D2 using an LC-ESI-MS/MS method with positive/negative ion-switching ionization modes: application to the study of anti-allergic flavonoids on the degranulation of KU812 cells. 2011 Anal Bioanal Chem pmid:21725829